Authors
Meagan Chambers, MD, MS, MSC
Department of Pathology and Laboratory Medicine
University of Washington
Seattle, Washington
Nicole Yarid, MD
King County Medical Examiner’s Office
Seattle, Washington
Primary Audience: Pathologists and Clinical Scientists
Secondary Audience: Residents, Laboratory Technologist/Scientist (Includes all sub-specialty areas), Students, Pathologist Assistants, Laboratory Directors and Educators
Upon completion of this activity, you will be able to:
· describe the acute pulmonary findings of fatal COVID-19;
· critically evaluate the evidence for and against coagulopathy as a unique finding in COVID-19
· contrast the proposed primary effects of COVID-19 in the heart and kidney with the postmortem findings attributed to preexisting conditions; and
· discuss the limitations in the literature with regard to pathologic findings of COVID-19.